Shikonin Induces Ferroptosis in DLBCL via lncRNA ADPGK-AS1 Downregulation
Shikonin suppresses DLBCL progression by inducing ferritinophagy and ferroptosis through lncRNA ADPGK-AS1 downregulation.
Asset / Drug
Drug and asset intelligence for Shikonin with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.